Market Overview

Alnylam Pharma Reports Offering of $125M in Stock

Related ALNY
Monday's After-Hours Recap: Index Movers, Alcoa's Earnings & More
JP Morgan Upgrades Alnylam Pharma To Overweight
Trouble Strikes Ionis; Will It Get Bought Out? By Gilead? (Seeking Alpha)

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading RNAi therapeutics company, today announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $125 million. All of the shares in the offering are to be sold by Alnylam.

Posted-In: News Offerings


Related Articles (ALNY)

View Comments and Join the Discussion!